Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 1201.90 | 21 / 21 | 100% | 45.11 | 504 / 504 |
brain | 100% | 2552.48 | 2641 / 2642 | 100% | 57.44 | 704 / 705 |
intestine | 100% | 1178.41 | 966 / 966 | 100% | 39.16 | 525 / 527 |
liver | 100% | 1505.65 | 226 / 226 | 99% | 30.44 | 403 / 406 |
uterus | 100% | 641.57 | 170 / 170 | 99% | 29.89 | 455 / 459 |
breast | 100% | 1308.67 | 459 / 459 | 99% | 21.74 | 1107 / 1118 |
lung | 99% | 1353.70 | 575 / 578 | 99% | 34.35 | 1148 / 1155 |
esophagus | 100% | 925.75 | 1442 / 1445 | 99% | 26.68 | 181 / 183 |
stomach | 99% | 675.88 | 354 / 359 | 100% | 36.51 | 286 / 286 |
prostate | 100% | 961.72 | 245 / 245 | 99% | 15.57 | 495 / 502 |
skin | 100% | 1105.66 | 1800 / 1809 | 97% | 18.70 | 459 / 472 |
ovary | 97% | 555.82 | 174 / 180 | 100% | 27.00 | 429 / 430 |
thymus | 99% | 704.58 | 645 / 653 | 97% | 28.95 | 585 / 605 |
kidney | 100% | 890.04 | 89 / 89 | 94% | 16.38 | 850 / 901 |
adrenal gland | 100% | 688.88 | 258 / 258 | 79% | 9.22 | 181 / 230 |
pancreas | 73% | 363.48 | 240 / 328 | 98% | 27.82 | 175 / 178 |
adipose | 100% | 1354.38 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 57.24 | 29 / 29 |
spleen | 100% | 2423.25 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 30.02 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 51.95 | 1 / 1 |
muscle | 100% | 1338.41 | 802 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 5032.43 | 927 / 929 | 0% | 0 | 0 / 0 |
heart | 96% | 856.63 | 828 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 89% | 509.42 | 1194 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 11.28 | 71 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0090200 | Biological process | positive regulation of release of cytochrome c from mitochondria |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_2001238 | Biological process | positive regulation of extrinsic apoptotic signaling pathway |
GO_0042129 | Biological process | regulation of T cell proliferation |
GO_2001244 | Biological process | positive regulation of intrinsic apoptotic signaling pathway |
GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
GO_2000045 | Biological process | regulation of G1/S transition of mitotic cell cycle |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_0097345 | Biological process | mitochondrial outer membrane permeabilization |
GO_2000271 | Biological process | positive regulation of fibroblast apoptotic process |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0008637 | Biological process | apoptotic mitochondrial changes |
GO_0097435 | Biological process | supramolecular fiber organization |
GO_0090150 | Biological process | establishment of protein localization to membrane |
GO_0050678 | Biological process | regulation of epithelial cell proliferation |
GO_0097284 | Biological process | hepatocyte apoptotic process |
GO_1902230 | Biological process | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
GO_0001836 | Biological process | release of cytochrome c from mitochondria |
GO_0042775 | Biological process | mitochondrial ATP synthesis coupled electron transport |
GO_0006626 | Biological process | protein targeting to mitochondrion |
GO_0010918 | Biological process | positive regulation of mitochondrial membrane potential |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0042770 | Biological process | signal transduction in response to DNA damage |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005829 | Cellular component | cytosol |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005123 | Molecular function | death receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | BID |
Protein name | BH3 interacting domain death agonist Si6 isoform BH3-interacting domain death agonist (p22 BID) (BID) [Cleaved into: BH3-interacting domain death agonist p15 (p15 BID); BH3-interacting domain death agonist p13 (p13 BID); BH3-interacting domain death agonist p11 (p11 BID)] BID isoform Si6 BH3-interacting domain death agonist |
Synonyms | hCG_21529 |
Description | FUNCTION: Induces caspases and apoptosis . Counters the protective effect of BCL2 (By similarity). .; FUNCTION: [BH3-interacting domain death agonist p15]: Induces caspase activation and apoptosis . Allows the release of cytochrome c . .; FUNCTION: [Isoform 1]: Induces ICE-like proteases and apoptosis. .; FUNCTION: [Isoform 2]: Induces ICE-like proteases and apoptosis. .; FUNCTION: [Isoform 3]: Does not induce apoptosis. .; FUNCTION: [Isoform 4]: Induces ICE-like proteases and apoptosis. . FUNCTION: Induces caspases and apoptosis. Counters the protective effect of BCL2. . |
Accessions | ENST00000342111.9 [P55957-3] B2ZP79 A8ASI8 ENST00000399767.6 [P55957-4] A0A2P1N6T5 P55957 ENST00000622694.5 [P55957-1] ENST00000551952.5 [P55957-1] A0A2P1N6U0 B2ZP78 ENST00000614949.4 [P55957-4] ENST00000399765.5 [P55957-4] ENST00000317361.11 [P55957-2] A0A2U9F3W7 |